SCHEMBL16657022

SCHEMBL16657022

CCn1ccc2oc(C)cc2c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.41
CYP1A1 P04798 5/20 0.41
CYP1B1 Q16678 5/20 0.41
KCNA5 P22460 5/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
KCNJ5 P48544 3/20 0.37
KCNJ3 P48549 3/20 0.37
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 2/20 0.34
ACHE P22303 1/20 0.34
MAPK1 P28482 1/20 0.34
MAPT P10636 2/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1236934 0.83 CYP1A2 (0.38) CYP1A2CYP1A1CYP1B1KCNA5SMN1; SMN2
SCHEMBL12080017 0.83 CYP1A2 (0.38) CYP1A2CYP1A1CYP1B1KCNA5SMN1; SMN2
SCHEMBL1238094 0.83 CYP1A1 (0.38) CYP1A2CYP1A1CYP1B1KCNA5KCNJ5
SCHEMBL1238322 0.80 KCNA5 (0.40) CYP1A2CYP1A1CYP1B1KCNA5KCNJ5
SCHEMBL16657021 0.80 MAPK14 (0.47) CYP1A2CYP1A1CYP1B1SMN1; SMN2KDM4E
SCHEMBL1238531 0.80 TNF (0.38) CYP1A2CYP1A1CYP1B1KCNA5KCNJ5
SCHEMBL16657020 0.77 CYP1A2 (0.44) CYP1A2CYP1A1CYP1B1SMN1; SMN2HTR2A
SCHEMBL16589139 0.75 CYP1A2 (0.41) CYP1A2CYP1A1CYP1B1SMN1; SMN2HTR2A
SCHEMBL1237162 0.71 USP2 (0.43) HTR2AKDM4EALDH1A1MAPK1MAPT
SCHEMBL18011104 0.69 ALDH1A1 (0.38) CYP1A2CYP1A1CYP1B1SMN1; SMN2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505772-B2 Aromatic ring compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-11-29 US disclosed
US-20150111894-A1 AROMATIC RING COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150111894-A1 AROMATIC RING COMPOUND MC1R, MC4R, TYR CYP1A2 777/4885CYP1A1 564/4885CYP1B1 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.